Ayble Health Raises $16M Series A

Ayble Health, based in Boston, Massachusetts, is an AI-enabled virtual multidisciplinary clinic focused on chronic digestive and autoimmune conditions. The company has announced the closing of a $16 million Series A funding round, bringing its total capital raised to over $27 million.

Investors

The round was led by Neon, an early-growth stage venture capital firm. Additional participating investors include Unum Ventures, Upfront Ventures, M13, Cleveland Clinic Ventures, DigiTx, Accomplice, and several individual strategic investors.

Ayble Health Use of Funds

Ayble Health plans to use the new capital to advance its proprietary AI and clinician precision care model, deepening data-driven personalization for patient engagement and care delivery. Additionally, the company will scale its multidisciplinary model to expand from its core gastrointestinal footprint into adjacent complex therapeutic areas, starting with autoimmune conditions.

About Ayble Health

Founded in 2021 by Sam Jactel, Ayble Health is a virtual clinic that provides patients with access to GI-trained providers, dietitians, behavioral health specialists, and clinical pharmacists. The company mission is to address the clinical and diagnostic gaps in digestive health by using a multidisciplinary care model supported by one of the largest GI-specific datasets in the world.

Funding Details

Company Website: https://ayblehealth.com

Company: Ayble Health
Raised: $16M
Round: Series A
Funding Date: September 16, 2026
Lead Investor: Neon
Additional Investors: Unum Ventures, Upfront Ventures, M13, Cleveland Clinic Ventures, DigiTx, Accomplice
Company Website: https://www.ayblehealth.com
Software Category: Digital Health
Source: https://www.prnewswire.com/news-releases/ayble-health-raises-16m-series-a-to-expand-the-nations-most-clinically-validated-virtual-digestive-health-clinic-302880020.html